Insights & Resources

Many business valuations begin with calculating a multiple of EBITDA (earnings before interest, taxes, depreciation, and amortization). In health care, however, valuators should deliberate just when and how to apply general valuation EBITDA transaction multiples for fair market value opinions.

Commentary from publicly traded Managed Care Organizations (MCOs) regarding their insurance spend expectations can be an excellent source of macroeconomic data for health care valuation professionals when projecting performance for provider entities.

Questions about the shelf life of a fair market value (FMV) opinion can arise when the parties seek certainty about compliance with government regulations or wish to maintain arrangements that are financially viable to all parties.

A long-awaited, thoughtful and clear document, Kubernetes Hardening Guidance, was published recently by the National Security Agency (NSA) and the Department of Homeland Security’s (DHS) Cybersecurity and Infrastructure Security Agency (CISA).

Professionals tasked with performing health care appraisals still face circumstantial challenges when performing their work fifteen months after the pandemic began. While a lot has changed, the basics of valuation have not.

Transactions for large hospice providers are yielding historically high multiples of EBITDA and revenue.

As one of the most widely read annual cybersecurity reports, the Verizon Data Breach Investigation Report (DBIR) offers interesting insights into cybercrime.